Denmark’s Lundbeck has opened its Gulf head quarters in Dubai. The company is a fully integrated pharmaceutical company focusing on finding new therapies for central nervous system (CNS) disorders.
Besides maintaining relations and becoming a specialist center for CNS disorders, Lundbeck will develop outreach programs in which the stigma around the people with these disorders can be removed and people can come out easily if they have any CNS disorders such as anxiety, depression, Alzheimer's disease, schizophrenia and Parkinson's disease.
Lundbeck also aims to be specialists in neurology. Over the last three years. It has built a strong product portfolio and pipeline in neurology. Currently, Lundbeck is marketed in more than 70 countries worldwide. — (menareport.com)
© 2003 Mena Report (www.menareport.com)
